Table 2 Medical and treatment characteristics
|  | Aged 17 or below (n = 20) | Aged 18 or above (n = 20) |
|---|---|---|
N (%) | N (%) | |
ADHD diagnosis | ||
Childhood | 20 (100) | 15 (75) |
Late adolescence/adulthood | - | 5 (25) |
Non-pharmacological treatment | ||
No treatment | 10 (48) | 12 (50) |
ADHD training/behavioural therapy | 8 (38) | 10 (42) |
Psychological counselling | 2 (10) | 1 (4) |
Both treatments | 1 (5) | 1 (4) |
Medication use | ||
Using medication | 17 (85) | 16 (80) |
Discontinued medication* | 3 (15) | 4 (20) |
Medication type** | ||
Methylphenidate | 19 (95) | 18 (90) |
Atomoxetine | 1 (5) | 1 (5) |
Clonidine | 0 (0) | 1 (5) |
Duration since diagnosis | ||
1-2 years | 0 (0) | 1 (5) |
3-4 years | 2 (10) | 2 (10) |
5+ years | 11 (55) | 9 (45) |
10-14 years | 7 (35) | 7 (35) |
15+ years | 0 (0) | 1 (5) |
Duration of medication*** (n = 37) | ||
Less than 1Â year | 2 (11) | 0 (0) |
1-2 years | 5 (26) | 3 (17) |
3-4 years | 1 (5) | 4 (22) |
5-9 years | 7 (37) | 7 (39) |
10-14 years | 4 (21) | 4 (22) |